These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9098261)

  • 41. Case of fertility treatment-induced Stevens-Johnson syndrome with a severe ocular complication.
    Hashimoto H; Miyachi H; Kataoka K; Maru Y; Togawa Y; Matsue H
    J Dermatol; 2019 Nov; 46(11):1042-1045. PubMed ID: 31489686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methazolamide and acetazolamide in acute mountain sickness.
    Wright AD; Bradwell AR; Fletcher RF
    Aviat Space Environ Med; 1983 Jul; 54(7):619-21. PubMed ID: 6349608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic markers for methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Huang PW; Chu CY
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):764. PubMed ID: 35536169
    [No Abstract]   [Full Text] [Related]  

  • 44. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
    Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ
    Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan.
    Chen KT; Twu SJ; Chang HJ; Lin RS
    Am J Public Health; 2003 Mar; 93(3):489-92. PubMed ID: 12604501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible cefotaxime-induced Stevens-Johnson syndrome.
    Liberopoulos EN; Liamis GL; Elisaf MS
    Ann Pharmacother; 2003 Jun; 37(6):812-4. PubMed ID: 12773067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma.
    Epstein RJ; Allen RC; Lunde MW
    Ann Ophthalmol; 1987 Feb; 19(2):48-50. PubMed ID: 3566023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The hypoxia-induced facilitation of augmented breaths is suppressed by the common effect of carbonic anhydrase inhibition.
    Bell HJ; Haouzi P
    Respir Physiol Neurobiol; 2010 May; 171(3):201-11. PubMed ID: 20382275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraocular pressure effects of carbonic anhydrase inhibitors in primary open-angle glaucoma.
    Lichter PR; Musch DC; Medzihradsky F; Standardi CL
    Am J Ophthalmol; 1989 Jan; 107(1):11-7. PubMed ID: 2643331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic association of IFN-γ +874T/A polymorphism in Mexican patients with drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Charli-Joseph Y; Lima G; Ramos-Bello D; Aguilar D; Orozco-Topete R; Llorente L
    Arch Dermatol Res; 2013 May; 305(4):353-7. PubMed ID: 23224615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome.
    Ueta M; Sotozono C; Inatomi T; Kojima K; Tashiro K; Hamuro J; Kinoshita S
    Br J Ophthalmol; 2007 Jul; 91(7):962-5. PubMed ID: 17314152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan.
    Kunimi Y; Hirata Y; Aihara M; Yamane Y; Ikezawa Z
    Allergol Int; 2011 Dec; 60(4):525-32. PubMed ID: 22113160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cephalexin-induced Stevens-Johnson syndrome.
    Murray KM; Camp MS
    Ann Pharmacother; 1992 Oct; 26(10):1230-3. PubMed ID: 1421644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.
    Chen JJ; Sohn EH; Folk JC; Mahajan VB; Kay CN; Boldt HC; Russell SR
    Retina; 2014 Jul; 34(7):1400-6. PubMed ID: 24451922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Carbonic Anhydrase Inhibitors: Epidemiology, Genetics, and Insights into Mechanisms.
    Trubiano JA; Ostrov DA; Phillips EJ
    J Allergy Clin Immunol Pract; 2019; 7(8):2854-2856. PubMed ID: 31706497
    [No Abstract]   [Full Text] [Related]  

  • 60. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
    Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
    Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.